Agilent Technologies Inc (A)
132.32
+0.26
(+0.20%)
USD |
NYSE |
Nov 22, 11:01
Agilent Technologies Revenue (Quarterly): 1.578B for July 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 1.578B |
| April 30, 2024 | 1.573B |
| January 31, 2024 | 1.658B |
| October 31, 2023 | 1.688B |
| July 31, 2023 | 1.672B |
| April 30, 2023 | 1.717B |
| January 31, 2023 | 1.756B |
| October 31, 2022 | 1.849B |
| July 31, 2022 | 1.718B |
| April 30, 2022 | 1.607B |
| January 31, 2022 | 1.674B |
| October 31, 2021 | 1.66B |
| July 31, 2021 | 1.586B |
| April 30, 2021 | 1.525B |
| January 31, 2021 | 1.548B |
| October 31, 2020 | 1.483B |
| July 31, 2020 | 1.261B |
| April 30, 2020 | 1.238B |
| January 31, 2020 | 1.357B |
| October 31, 2019 | 1.367B |
| July 31, 2019 | 1.274B |
| April 30, 2019 | 1.238B |
| January 31, 2019 | 1.284B |
| October 31, 2018 | 1.294B |
| July 31, 2018 | 1.203B |
| Date | Value |
|---|---|
| April 30, 2018 | 1.206B |
| January 31, 2018 | 1.211B |
| October 31, 2017 | 1.189B |
| July 31, 2017 | 1.114B |
| April 30, 2017 | 1.102B |
| January 31, 2017 | 1.067B |
| October 31, 2016 | 1.111B |
| July 31, 2016 | 1.044B |
| April 30, 2016 | 1.019B |
| January 31, 2016 | 1.028B |
| October 31, 2015 | 1.035B |
| July 31, 2015 | 1.014B |
| April 30, 2015 | 963.00M |
| January 31, 2015 | 1.026B |
| October 31, 2014 | 1.043B |
| July 31, 2014 | 1.009B |
| April 30, 2014 | 988.00M |
| January 31, 2014 | 1.008B |
| October 31, 2013 | -1.17B |
| July 31, 2013 | 1.652B |
| April 30, 2013 | 1.732B |
| January 31, 2013 | 1.68B |
| October 31, 2012 | 1.767B |
| July 31, 2012 | 1.723B |
| April 30, 2012 | 1.733B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.238B
Minimum
Apr 2020
1.849B
Maximum
Oct 2022
1.587B
Average
1.607B
Median
Apr 2022
Revenue (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 649.73M |
| Bruker Corp | 864.40M |
| Azenta Inc | 170.06M |
| Harvard Bioscience Inc | 21.97M |
| Phibro Animal Health Corp | 260.43M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 282.00M |
| Total Expenses (Quarterly) | 1.245B |
| EPS Diluted (Quarterly) | 0.97 |
| Enterprise Value | 39.10B |
| Gross Profit Margin (Quarterly) | 54.18% |
| Profit Margin (Quarterly) | 17.87% |
| Earnings Yield | 3.64% |
| Operating Earnings Yield | 3.83% |
| Normalized Earnings Yield | 3.643 |